We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

206 hedge funds and large institutions have $1.55B invested in Imperva, Inc. in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 70 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 16

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

18% more funds holding

Funds holding: 175206 (+31)

13% more capital invested

Capital invested by funds: $1.37B → $1.55B (+$178M)

13% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 62

27% less call options, than puts

Call options by funds: $3.07M | Put options by funds: $4.22M

Holders
206
Holders Change
+31
Holders Change %
+17.71%
% of All Funds
4.72%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
49
Increased
70
Reduced
62
Closed
16
Calls
$3.07M
Puts
$4.22M
Net Calls
-$1.16M
Net Calls Change
-$2.44M
Name Holding Trade Value Shares
Change
Change in
Stake
MIM
126
MetLife Investment Management
New Jersey
$682K
VOYA Investment Management
127
VOYA Investment Management
Georgia
$644K
QT
128
Quantbot Technologies
New York
$634K -$320K -7,122 -33%
T. Rowe Price Associates
129
T. Rowe Price Associates
Maryland
$625K +$5.66K +126 +0.9%
Capital Fund Management (CFM)
130
Capital Fund Management (CFM)
France
$602K +$624K +13,900 New
QIM
131
Quantitative Investment Management
Virginia
$593K +$615K +13,700 New
GCP
132
GSA Capital Partners
United Kingdom
$585K +$256K +5,704 +73%
DTL
133
Dynamic Technology Lab
Singapore
$555K -$182K -4,045 -24%
SGI
134
Summit Global Investments
Utah
$546K +$566K +12,600 New
PPA
135
Parametric Portfolio Associates
Washington
$526K -$18.9K -421 -3%
HWA
136
HCR Wealth Advisors
California
$520K -$225K -5,000 -29%
IR
137
Invictus RG
Bermuda
$512K +$531K +11,832 New
GIPM
138
G2 Investment Partners Management
New York
$489K +$507K +11,300 New
MLICM
139
Metropolitan Life Insurance Company (MetLife)
New York
$484K +$12.9K +287 +3%
GFPC
140
Global Financial Private Capital
Florida
$477K -$55.4K -1,234 -10%
SG Americas Securities
141
SG Americas Securities
New York
$461K +$478K +10,636 New
FRM
142
Fox Run Management
Connecticut
$459K -$21K -468 -4%
Verition Fund Management
143
Verition Fund Management
Connecticut
$449K +$466K +10,376 New
CSS
144
Cubist Systematic Strategies
Connecticut
$436K +$155K +3,448 +52%
CM
145
Crestline Management
Texas
$433K +$449K +10,000 New
KI
146
Koch Industries
Kansas
$414K +$170K +3,791 +66%
BCM
147
Bayesian Capital Management
New York
$391K +$405K +9,027 New
RG
148
Renaissance Group
Kentucky
$382K +$10.2K +228 +3%
VanEck Associates
149
VanEck Associates
New York
$382K +$26.4K +588 +7%
BCM
150
BlueCrest Capital Management
Jersey
$377K +$391K +8,697 New

IMPV Hedge Fund Activity: Q1 2018 in Review

206 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q1 2018, worth a combined $1.55B — up 13% from $1.37B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new IMPV positions and 16 closed out — a net gain of 33 holders — while 70 added to existing stakes and 62 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $29M. The largest seller was Alyeska Investment Group, cutting an estimated $38.5M.

  • 206 institutional investors held Imperva, Inc. (IMPV) as of Q1 2018, up from 175 in Q4 2017.
  • Funds reported $1.55B of Imperva, Inc. stock for Q1 2018, up 13% quarter-over-quarter.
  • 49 funds opened new Imperva, Inc. positions in Q1 2018 and 16 closed out, a net change of +33 holders.
  • The largest Imperva, Inc. buyer in Q1 2018 was Goldman Sachs, an estimated $29M added.
  • The largest Imperva, Inc. seller in Q1 2018 was Alyeska Investment Group, an estimated $38.5M sold.

Based on aggregated 13F filings for Q1 2018.